Edition:
United States

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

40.52USD
22 Feb 2019
Change (% chg)

$0.40 (+1.00%)
Prev Close
$40.12
Open
$40.27
Day's High
$40.81
Day's Low
$40.18
Volume
2,063,120
Avg. Vol
1,941,250
52-wk High
$40.81
52-wk Low
$26.27

Select another date:

Tue, Jan 15 2019

Edward Lifesciences pays Boston Scientific $180 million to end patent row

Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

UPDATE 2-Edward Lifesciences pays Boston Scientific $180 mln to end patent row

Jan 15 Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

Edward Lifesciences settles patent disputes with Boston Scientific

Jan 15 Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement related to all outstanding patent disputes between the companies, the medical device makers said in a joint statement on Tuesday.

Edwards owes Boston Scientific $35 mln in heart valve patent case - jury

A federal jury in Delaware has ordered medical device maker Edwards Lifesciences Corp to pay $35 million after finding a heart valve replacement system it makes infringes a patent held by rival Boston Scientific Corp.

Boston Scientific backs BTG offer with £3.3bn bridge loan

LONDON, Nov 21 (LPC) - US medical device maker Boston Scientific is backing its recommended cash offer for UK-based BTG plc with a £3.3bn (US$4.22bn)bridge loan from Barclays Bank.

Boston Scientific backs BTG offer with £3.3bn bridge loan

LONDON, Nov 20 (LPC) - US medical device maker Boston Scientific is backing its recommended cash offer for UK-based BTG plc with a £3.3bn bridge loan from Barclays Bank.

Boston Scientific builds medical technology with $4.2 billion BTG deal

LONDON U.S. medical device maker Boston Scientific Corp has agreed to buy Britain's BTG Plc for 3.3 billion pounds ($4.24 billion) in cash, adding technology to fight cancer and other serious diseases to its portfolio.

UPDATE 2-Boston Scientific builds medical tech with $4.2 billion BTG deal

* U.S. group's biggest deal since 2006 Guidant acquisition (Adds latest shares, analyst comment, further details)

Boston Scientific offers to buy UK's BTG for about $4.24 billion

Nov 20 U.S. medical device maker Boston Scientific Corp said it offered to buy British pharmaceutical firm BTG Plc for about 3.3 billion pounds ($4.24 billion) in cash.

Surgical product sales drive Boston Scientific's profit beat

Medical device company Boston Scientific Corp posted a slightly better-than-expected quarterly profit on Wednesday, helped by higher sales in its MedSurg business, which makes surgical products for various urological and pelvic disorders.

Select another date: